Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Aarti Drugs's OCF Margin % or its related term are showing as below:
BOM:524348'
s OCF Margin % Range Over the Past 10 Years
Min: 2.83 Med: 9.53 Max: 14.62
Current: 9.88
During the past 13 years, the highest OCF Margin % of Aarti Drugs was 14.62%. The lowest was 2.83%. And the median was 9.53%.
BOM:524348's OCF Margin % is ranked worse than 50.62% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs BOM:524348: 9.88
Aarti Drugs OCF Margin % Related Terms
Aarti Drugs OCF Margin % Historical Data
* Premium members only.
The historical data trend for Aarti Drugs's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aarti Drugs OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Aarti Drugs's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aarti Drugs (BOM:524348) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aarti Drugs and its competitors. Over the past decade, Aarti Drugs' OCF Margin % has ranged from 2.83 to 14.62. According to the industry distribution chart, Aarti Drugs ranks #488 out of 964 companies in the Drug Manufacturers industry, placing it in the top 50.6%.
Is Aarti Drugs' OCF Margin % too high?
Aarti Drugs' current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 2.83 to a high of 14.62. Based on the distribution chart, Aarti Drugs ranks #488 out of 964 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aarti Drugs has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aarti Drugs' OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Aarti Drugs ranks #488 out of 964 companies for OCF Margin %. This places Aarti Drugs in the lower half of its industry. The industry median OCF Margin % is 10.04. Historically, Aarti Drugs' own OCF Margin % has ranged from 2.83 to 14.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aarti Drugs and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aarti Drugs's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarti Drugs stock overvalued right now?
Based on GuruFocus' analysis, Aarti Drugs (BOM:524348) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹498.91, compared to a current price of ₹404.65 — trading 18.9% below its estimated fair value. The current OCF Margin % is 0.00%. Aarti Drugs' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aarti Drugs (BOM:524348), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aarti Drugs (BOM:524348) Overvalued in 2026?
Based on GuruFocus' analysis, Aarti Drugs stock appears to be undervalued.
The current stock price of ₹404.65 is trading 18.9% below its estimated GF Value™ of ₹498.91.
GuruFocus considers Aarti Drugs to be Modestly Undervalued.
Key valuation signals for BOM:524348:
OCF Margin %: 0.00%
GF Value™: ₹498.91 vs. price of ₹404.65 (18.9% below fair value)
No single metric tells the full story. See the BOM:524348 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.
65GF Score
Get the complete analysis for BOM:524348
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524348 has been successfully added to your 
